04. ASSESSMENT OF EFFICACY AND SAFETY OF OSIMERTINIB FOR PATIENTS WITH INTRACRANIAL METASTATIC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

INTRODUCTION: Intracranial metastatic disease (IMD) is a serious and life-altering complication for many patients with cancer. Targeted therapy may address limitations of current treatments as an additional agent to achieve intracranial disease control in some patients with IMD. Osimertinib is a mut...

Descripción completa

Detalles Bibliográficos
Autores principales: Erickson, Anders, Brastianos, Priscilla, Das, Sunit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401362/
http://dx.doi.org/10.1093/noajnl/vdaa073.000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401362/
http://dx.doi.org/10.1093/noajnl/vdaa073.000

Ejemplares similares